Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OP-145 ear drops for chronic suppurative otitis media in adults
ISRCTN12149720Phase 2Completed
- Sponsor
- OctoPlus
- Start
- Sep 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of OP-145 in chronic suppurative otitis media (CSOM) (2 arms), sponsored by OctoPlus. Primary endpoint: Safety of OP-145. Started Sep 2006; status: completed.
02
Drugs
OP-145
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on ISRCTN12149720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12149720.